The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
about
Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancersCyclin D as a therapeutic target in cancerCyclins: roles in mitogenic signaling and oncogenic transformationETS-targeted therapy: can it substitute for MEK inhibitors?Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasionThe oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisDmp1α inhibits HER2/neu-induced mammary tumorigenesis.Transgenic and knockout mice models to reveal the functions of tumor suppressor genes.Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.Cell cycle control in breast cancer cells.CDK4: A Key Player in the Cell Cycle, Development, and CancerComparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.Nuclear cyclin D1: an oncogenic driver in human cancer.Clinical applications of mouse models for breast cancer engaging HER2/neu.Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.Cell Cycle Regulation in Treatment of Breast Cancer.Targeting cell cycle kinases and kinesins in anticancer drug development.
P2860
Q24309483-101BDD0A-0A8E-4CED-925C-ED4EF72935D0Q28242623-C2652093-B160-46A7-973F-ED251CFE0294Q28289852-FA2DCB82-8BDB-4350-BE74-BFF75ACFD98EQ33638827-D8FA94A1-5481-439B-8787-1A91C56FAB0BQ33739855-49D7D31E-F025-4508-8FDA-69CBD01B73C5Q34493341-7DB7C089-B670-4400-9EC6-3842A5CB6CE4Q35035710-6A1B6385-AA1B-4A4D-A919-5AB3B12D98DBQ35155473-453CDDD8-AC1A-4B09-8318-4BF65839842BQ36120794-2BE084AA-E889-44D5-8F0D-FC418929C9BFQ36305565-ADE05291-8234-44C3-9A4F-D2AD35CAEA58Q36796424-EF8FD52C-2221-48FA-A819-2DFC94C52724Q36940496-1463DF49-5963-41E5-9C44-B0198F10C07CQ37218223-0051033D-273E-4E37-88F2-1D91CA4D493DQ37470373-ABC7C0D2-36B9-409B-BBDF-121BB511A2BBQ37607675-64615C50-33BA-49ED-82C0-0596B537E0D4Q40063650-59D6C51D-6B41-4818-8BD8-EE6F6827EA69Q49544319-E06A08DB-4084-47D8-BDC1-50831BD852B5Q52639097-7386D0C6-249B-4021-AB86-814025F575D5
P2860
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
@ast
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
@en
type
label
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
@ast
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
@en
prefLabel
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
@ast
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
@en
P2093
P2860
P1476
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
@en
P2093
Chuanwei Yang
David N Louis
Dennis Sgroi
Emmett V Schmidt
Karen Burns
Lawrence Zukerberg
Michelle Gadd
Viviana Ionescu-Tiba
P2860
P304
P356
10.1016/S0002-9440(10)63190-2
P407
P577
2004-03-01T00:00:00Z